首页> 外文期刊>International Urology and Nephrology >Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis.
【24h】

Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis.

机译:微血管密度作为膀胱癌的预后标志物:与肿瘤分级,分期和预后的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: The aim of our study was to evaluate tumor angiogenesis as a prognostic marker of transitional cell carcinoma of the bladder and to asses its relationship to established variables for survival and response to therapy. PATIENTS AND METHOD: Microvessel density (MVD), a measure of tumor angiogenesis, were evaluated in 77 primary bladder cancers. Forty-three superficial carcinomas and 34 invasive carcinomas were analysed. Tumor specimens of all patients were obtained by transurethral resection (TUR) and all the tumors were transitional cell carcinomas. Twenty-two patients with invasive bladder cancer have undergone M-VEC chemotheraphy. The correlation between MVD and histopathological grade, tumor stage and prognosis was evaluated. MVD was identified by immunostaining of endothelial cells using anti-CD34 antibody. For statistical analysis Kruskal-Vallis, Mann-Whitney U and Fisher's exact tests were used. RESULTS: MVD was correlated with tumor grade, stage and prognosis. Significantly higher MVD was determined in invasive tumors than superficial tumors (p < 0.05). MVD increased with tumor grade and stage (p < 0.05). High MVD was correlated with the risk of clinical progression in both superficial and invasive bladder carcinomas (p < 0.05, p < 0.001 respectively). Invasive tumors with remission after M-VEC chemotheraphy had lower MVD than tumors with progression after M-VEC. CONCLUSION: These data demonstrate that MVD in bladder carcinoma correlates with grade, stage and malignant potential of the tumor. Quantification of tumor angiogenesis may allow selection of the type of treatment for bladder cancer patients.
机译:引言:我们研究的目的是评估肿瘤血管生成作为膀胱移行细胞癌的预后标志物,并评估其与确定的生存率和对治疗反应的关系。患者与方法:在77例原发性膀胱癌中评估了微血管密度(MVD),作为衡量肿瘤血管生成的指标。分析了43例浅表癌和34例浸润癌。所有患者的肿瘤标本均通过经尿道切除术(TUR)获得,所有肿瘤均为移行细胞癌。 22名浸润性膀胱癌患者接受了M-VEC化疗。评价MVD与组织病理学分级,肿瘤分期和预后的相关性。 MVD通过使用抗CD34抗体对内皮细胞进行免疫染色来鉴定。为了进行统计分析,使用了Kruskal-Vallis,Mann-Whitney U和Fisher的精确检验。结果:MVD与肿瘤的分级,分期和预后相关。在浸润性肿瘤中确定的MVD明显高于浅表性肿瘤(p <0.05)。 MVD随肿瘤等级和分期而增加(p <0.05)。高MVD与浅表性和浸润性膀胱癌的临床进展风险相关(分别为p <0.05,p <0.001)。 M-VEC化疗后缓解的浸润性肿瘤的MVD低于M-VEC后进展的肿瘤。结论:这些数据表明膀胱癌中的MVD与肿瘤的分级,分期和恶性程度相关。肿瘤血管生成的量化可以允许选择用于膀胱癌患者的治疗类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号